Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #899

    tilfredsstillende effekt

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #900

      A Detroit-area doctor who authorities say gave cancer treatment drugs to patients who did not need them -- including some who didn't actually have cancer -- was sentenced Friday to 45 years in prison..... https://edition.cnn.com/2015/07/10/us/michigan-cancer-doctor-sentenced/index.html

      1 Reply Last reply
      0
      • N Offline
        N Offline
        nsrafk
        wrote on sidst redigeret af
        #901

        sick

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #902

          Det kan ikke komme bag på nogen - ikke engang markedet - at genmab går efter 50-50 aftaler. Hvis ash viser det imødesete poc for cd3xcd20 vil det nye år formentlig bringe en sådan aftale. Jeg kan ikke se andet end at det vil blive vel modtaget, selv om genmab kommer til at bruge en væsentlig del af sine kontanter til at føre stoffet videre.

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #903

            Når det sammenholdes med en +4mia guidance i februar, skal 2020 nok starte godt. Men indtil da tror jeg ikke rigtig, der sker det store, med mindre da at nogen ønsker at positionere sig inden situationen opstår.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #904

              2½ mia milestenen er stensikker. Den ventes af alle, og vil ikke rykke noget. 3 mia milestenen kommer der først nyt om ved nytår, så det rykker heller ikke noget lige med det første.

              1 Reply Last reply
              0
              • P Offline
                P Offline
                Plimsoller
                wrote on sidst redigeret af
                #905

                Der kan jo ligeså godt blive til +10% som det kan blive -10% resten af året.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #906

                  Jo, og når vi nu ser hvad der sker ovre i AMBU, kan shortinddækning også komme på tale allerede i år.

                  1 Reply Last reply
                  0
                  • nohopeN Offline
                    nohopeN Offline
                    nohope
                    wrote on sidst redigeret af
                    #907

                    Cup with handle - jeg kan godt få øje på håndtaget nu, det sidder desværre ovre på AMBU.

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #908

                      ResearchGate - Temporarily Unavailable

                      favicon

                      (www.researchgate.net)

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #909

                        Måske en kommende kandidat hen ad vejen:

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #910

                          Lidt ASH kommentarer - spændende med mulig late breaker for GSKs BCMA ADC

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #911

                            301 Moved Permanently

                            favicon

                            (www.evaluate.com)

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #912

                              maybe the full article clarifies a bit
                              http://sci-hub.tw/https://www.tandfonline.com/doi/abs/10.1080/2162402X.2019.1648171?journalCode=koni20 . Or maybe not. 😄

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #913

                                it works for me, in Chrome and Internet Explorer ?

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #914

                                  timing wise it would makes sense as BioNtech and Aduro/BioNovion both partnered with Genmab in 2015? if i am not mistaken...

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #915

                                    so given recent trials with BioNtech I mean, could be time for Aduro

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #916

                                      “The achievement of starting a Phase I/IIa clinical trial with a product candidate developed in only four years is a validation of our highly productive partnership with Genmab,” said Prof. Ugur Sahin, CEO of BioNTech - RE timing

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #917

                                        Aduro and Genmab has terminated their collaboration

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #918

                                          o really? i missed that...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger